Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Vaughn Kailian

Affiliations

  • Other at Radius Health Inc. (RDUS), 2016-09-29
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-09
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Chiasma Inc (CHMA), 2015-07-21
  • Large Shareholder at Trivascular Technologies Inc. (TRIV), 2014-04-23
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2014-03-12
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Large Shareholder at Conatus Pharmaceuticals Inc (CNAT), 2013-08-01
  • Other at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-13
  • Other at Verastem Inc. (VSTM), 2012-02-03
  • Director at Cephalon Inc (CEPH), 2011-10-17
  • Large Shareholder at Peplin Inc (PLIN), 2009-11-13
  • Large Shareholder, Director at Memory Pharmaceuticals Corp (MEMY), 2009-01-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PCRX $6.50 461,538 Large Shareholder 3,290,479 2011-11-21 Filing
PCRX $7.00 267,857 Large Shareholder 2,828,941 2011-02-08 Filing
PCRX $7.00 267,857 Large Shareholder 2,561,084 2011-02-08 Filing
PCRX $7.00 267,857 Large Shareholder 2,828,941 2012-02-08 Filing
PCRX $7.00 267,857 Large Shareholder 2,561,084 2012-02-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PCRX $27.86 500,000 Other 2,790,479 2013-03-11 Filing